Aclaris Therapeutics, Inc. (ACRS)
$6.01-$0.15 (-2.44%) Today
Aclaris Therapeutics Inc is a clinical-stage biopharmaceutical company. It focuses on developing novel drug candidates for immuno-inflammatory diseases using its proprietary KINect drug discovery platform. The company's pipeline consists of the following key product candidates: Bosakitug (ATI-045), an investigational, novel, humanized anti-TSLP monoclonal antibody being developed for patients with severe asthma, COPD, and chronic rhinosinusitis with nasal polyps; ATI-2138, being developed for the potential treatment of T cell-mediated autoimmune diseases; and ATI-052 and ATI-9494. Additionally, it has an investigational product candidate, Lepzacitinib (ATI-1777), which is being focused upon as a potential treatment for atopic dermatitis and potentially other dermatologic conditions.
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Grant or award | 12 | 320,022 | |
| Option exercise | 14 | 211,710 | |
| Tax withholding / forfeiture | 1 | 12,385 |
Dollar totals are shown for open-market purchases and sales only. Grants, option exercises, gifts and tax withholding are reported by share count because they are not trades at a market price.
34 Form 4 filings on record, the earliest from Oct 3, 2024, newest first. Filing history page 1 of 2.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Roland Wilhelm Kolbeck - Officer | Option exercise | Common Stock | 36,375 | - | - | |
| Roland Wilhelm Kolbeck - Officer | Tax withholding / forfeiture | Common Stock | 12,385 | $5.20 | $64K | |
| Roland Wilhelm Kolbeck - Officer | Option exercise | Restricted Stock Units | 36,375 | $0.00 | - | |
| Anand Mehra | Option exercise | Common Stock | 11,580 | - | - | |
| Anand Mehra | Grant or award | Stock Option (Right to Buy) | 42,350 | $0.00 | - | |
| Anand Mehra | Grant or award | Restricted Stock Units | 10,987 | $0.00 | - | |
| Anand Mehra | Option exercise | Restricted Stock Units | 11,580 | $0.00 | - | |
| Andrew N. Schiff | Option exercise | Common Stock | 11,580 | - | - | |
| Andrew N. Schiff | Grant or award | Stock Option (Right to Buy) | 42,350 | $0.00 | - | |
| Andrew N. Schiff | Grant or award | Restricted Stock Units | 10,987 | $0.00 | - | |
| Andrew N. Schiff | Option exercise | Restricted Stock Units | 11,580 | $0.00 | - | |
| William D. Humphries | Option exercise | Common Stock | 11,580 | - | - | |
| William D. Humphries | Grant or award | Stock Option (Right to Buy) | 42,350 | $0.00 | - | |
| William D. Humphries | Grant or award | Restricted Stock Units | 10,987 | $0.00 | - | |
| William D. Humphries | Option exercise | Restricted Stock Units | 11,580 | $0.00 | - | |
| Christopher P. Molineaux | Option exercise | Common Stock | 11,580 | - | - | |
| Christopher P. Molineaux | Grant or award | Stock Option (Right to Buy) | 42,350 | $0.00 | - | |
| Christopher P. Molineaux | Grant or award | Restricted Stock Units | 10,987 | $0.00 | - | |
| Christopher P. Molineaux | Option exercise | Restricted Stock Units | 11,580 | $0.00 | - | |
| Vincent Milano | Option exercise | Common Stock | 11,580 | - | - | |
| Vincent Milano | Grant or award | Stock Option (Right to Buy) | 42,350 | $0.00 | - | |
| Vincent Milano | Grant or award | Restricted Stock Units | 10,987 | $0.00 | - | |
| Vincent Milano | Option exercise | Restricted Stock Units | 11,580 | $0.00 | - | |
| Maxine Gowen | Grant or award | Stock Option (Right to Buy) | 42,350 | $0.00 | - | |
| Maxine Gowen | Grant or award | Restricted Stock Units | 10,987 | $0.00 | - | |
| Maxine Gowen | Option exercise | Restricted Stock Units | 11,580 | $0.00 | - | |
| Maxine Gowen | Option exercise | Common Stock | 11,580 | - | - | |
 Jesse Wayne Hall - Officer | Option exercise | Common Stock | 36,375 | - | - | |
| Jesse Wayne Hall - Officer | Tax withholding / forfeiture | Common Stock | 9,330 | $4.41 | $41K | |
| Jesse Wayne Hall - Officer | Option exercise | Restricted Stock Units | 36,375 | $0.00 | - | |
| Braden Michael Leonard | Open-market sale | Common Stock | 300,000 | $4.53 | $1.36M | |
 Kevin Balthaser - Officer | Option exercise | Common Stock | 2,375 | - | - | |
| Kevin Balthaser - Officer | Tax withholding / forfeiture | Common Stock | 677 | $2.87 | $2K | |
| Kevin Balthaser - Officer | Option exercise | Restricted Stock Units | 2,375 | $0.00 | - | |
 Neal Walker - Officer | Grant or award | Restricted Stock Units | 274,800 | $0.00 | - | |
| Neal Walker - Officer | Grant or award | Employee Stock Option (Right to Buy) | 961,700 | $0.00 | - | |
| Hugh M. Davis - Officer | Grant or award | Restricted Stock Units | 96,100 | $0.00 | - | |
| Hugh M. Davis - Officer | Grant or award | Employee Stock Option (Right to Buy) | 336,300 | $0.00 | - | |
| Roland Wilhelm Kolbeck - Officer | Grant or award | Restricted Stock Units | 95,700 | $0.00 | - | |
| Roland Wilhelm Kolbeck - Officer | Grant or award | Employee Stock Option (Right to Buy) | 334,900 | $0.00 | - | |
| Jesse Wayne Hall - Officer | Grant or award | Restricted Stock Units | 98,100 | $0.00 | - | |
| Jesse Wayne Hall - Officer | Grant or award | Employee Stock Option (Right to Buy) | 343,300 | $0.00 | - | |
 James Loerop - Officer | Grant or award | Restricted Stock Units | 97,700 | $0.00 | - | |
| James Loerop - Officer | Grant or award | Employee Stock Option (Right to Buy) | 341,900 | $0.00 | - | |
| Kevin Balthaser - Officer | Grant or award | Restricted Stock Units | 99,100 | $0.00 | - | |
| Kevin Balthaser - Officer | Grant or award | Employee Stock Option (Right to Buy) | 346,800 | $0.00 | - | |
| James Loerop - Officer | Option exercise | Common Stock | 20,875 | - | - | |
| James Loerop - Officer | Tax withholding / forfeiture | Common Stock | 5,937 | $3.47 | $21K | |
| James Loerop - Officer | Option exercise | Restricted Stock Units | 20,875 | $0.00 | - | |
| Neal Walker - Officer | Option exercise | Common Stock | 63,475 | - | - | |
| Neal Walker - Officer | Tax withholding / forfeiture | Common Stock | 18,611 | $3.47 | $65K | |
| Neal Walker - Officer | Option exercise | Restricted Stock Units | 63,475 | $0.00 | - | |
| Hugh M. Davis - Officer | Option exercise | Common Stock | 18,675 | - | - | |
| Hugh M. Davis - Officer | Option exercise | Restricted Stock Units | 18,675 | $0.00 | - | |
| Kevin Balthaser - Officer | Option exercise | Common Stock | 22,025 | - | - | |
| Kevin Balthaser - Officer | Tax withholding / forfeiture | Common Stock | 6,449 | $3.47 | $22K | |
| Kevin Balthaser - Officer | Option exercise | Restricted Stock Units | 22,025 | $0.00 | - | |
| Kevin Balthaser - Officer | Option exercise | Common Stock | 14,750 | - | - | |
| Kevin Balthaser - Officer | Tax withholding / forfeiture | Common Stock | 4,984 | $3.51 | $17K | |
| Kevin Balthaser - Officer | Option exercise | Restricted Stock Units | 14,750 | $0.00 | - | |
| James Loerop - Officer | Tax withholding / forfeiture | Common Stock | 15,980 | $2.48 | $40K | |
| Hugh M. Davis - Officer | Option exercise | Common Stock | 26,750 | - | - | |
| Hugh M. Davis - Officer | Option exercise | Restricted Stock Units | 26,750 | $0.00 | - | |
| Roland Wilhelm Kolbeck - Officer | Grant or award | Restricted Stock Units | 145,500 | $0.00 | - | |
| Roland Wilhelm Kolbeck - Officer | Grant or award | Employee Stock Option (right to buy) | 510,000 | $0.00 | - | |
| Andrew N. Schiff | Option exercise | Common Stock | 4,793 | - | - | |
| Andrew N. Schiff | Grant or award | Stock Option (Right to Buy) | 42,350 | $0.00 | - | |
| Andrew N. Schiff | Grant or award | Restricted Stock Units | 11,580 | $0.00 | - | |
| Andrew N. Schiff | Option exercise | Restricted Stock Units | 4,793 | $0.00 | - | |
| Maxine Gowen | Option exercise | Common Stock | 4,793 | - | - | |
| Maxine Gowen | Grant or award | Stock Option (Right to Buy) | 42,350 | $0.00 | - | |
| Maxine Gowen | Grant or award | Restricted Stock Units | 11,580 | $0.00 | - | |
| Maxine Gowen | Option exercise | Restricted Stock Units | 4,793 | $0.00 | - | |
| Vincent Milano | Option exercise | Common Stock | 4,793 | - | - | |
| Vincent Milano | Grant or award | Stock Option (Right to Buy) | 42,350 | $0.00 | - | |
| Vincent Milano | Grant or award | Restricted Stock Units | 11,580 | $0.00 | - | |
| Vincent Milano | Option exercise | Restricted Stock Units | 4,793 | $0.00 | - | |
| Joseph Monahan - Officer | Gift | Common Stock | 15,000 | $0.00 | - | |
| Neal Walker - Officer | Option exercise | Common Stock | 118,840 | $1.52 | $181K | |
| Neal Walker - Officer | Tax withholding / forfeiture | Common Stock | 68,343 | $3.76 | $257K | |
| Neal Walker - Officer | Option exercise | Employee Stock Option (right to buy) | 118,840 | $0.00 | - | |
| Hugh M. Davis - Officer | Grant or award | Employee Stock Option (Right to Buy) | 375,000 | $0.00 | - | |
| Hugh M. Davis - Officer | Grant or award | Restricted Stock Units | 107,000 | $0.00 | - |
Aclaris Therapeutics, Inc. (ACRS) had 7 insider filings in the last 90 days, with the most recent on 2026-08-04. The full record for ACRS runs to 34 Form 4 filings, the earliest from 2024-10-03. InsiderAlpha tracks every Form 4, Form 144, and 8-K filing in real time.
No insider purchases of ACRS were filed in the last 90 days. 1 purchase is on record for this company.
No insider sales of ACRS were filed in the last 90 days. 1 sale is on record for this company.
This page tracks ACRS Form 4 insider transactions, Form 144 sale notices, and 8-K material event disclosures in one timeline. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
Create a free InsiderAlpha account and press Watch on this page to add ACRS to your watchlist. A free account also opens the full scored daily plan with every past day and 3 months of price history. No card is required. Sign up at https://insideralpha.ai/register.
Every Form 4 below links to the original document on SEC EDGAR, so the numbers on this page can be checked against the filing they came from.
Real-time Form 4 alerts, AI-scored daily trade ideas and 10b5-1 plan flags.
